Involvement of microRNA families in cancer

Stefan Wuchty1, Dolores Arjona, Serdar Bozdag

  • 1National Center of Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894, USA. wuchtys@ncbi.nlm.nih.gov

Insights

This study identifies highly interacting microRNA (miR) families involved in cancer by analyzing gene interactions and pathway involvement. The findings predict novel candidate cancer miRs, aiding in understanding cancer mechanisms.

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Biology

Background:

  • MicroRNAs (miRs) play crucial roles in gene regulation and are implicated in various diseases, including cancer.
  • Identifying specific miRs and their families involved in cancer pathogenesis is essential for developing targeted therapies.

Purpose of the Study:

  • To identify and predict novel cancer-associated microRNA families based on their interaction profiles with cancer genes and pathways.
  • To develop a method for predicting candidate cancer miR families beyond simple counts of targeted genes.

Main Methods:

  • Collected literature-based sets of cancer microRNAs (miRs) and analyzed their family interactions.
  • Clustered miR family-specific pathway intervention profiles to identify shared interaction patterns.
  • Developed a predictive method based on gene-specific interaction profiles to identify candidate cancer miR families.

Main Results:

  • Cancer microRNA families are enriched in highly interacting families and significantly target cancer genes within signaling pathways.
  • Clustering revealed shared interaction patterns among different miR families, suggesting potential roles in cancer.
  • A predictive method identified 84 candidate miR families, including 75% of known cancer miRs, with significant associations across tumor types.

Conclusions:

  • The study provides a novel approach to predict cancer-associated microRNA families based on interaction networks, moving beyond simple gene targeting metrics.
  • The identified candidate miR families represent promising targets for further investigation in cancer research and therapeutic development.
  • These findings highlight the complex regulatory roles of microRNA families in cancer development and progression.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...